This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Amicus Therapeutics Inc (FOLD)

NASDAQ: Health Care

Company Balance Sheet
Dec 2013 Dec 2012 Dec 2011 Dec 2010
Assets
Cash and Equivalents 43.64M 33.97M 25.67M 29.57M
Receivables 759.00K 3.22M 5.04M 0.00
Inventories 0.00 0.00 0.00 0.00
Other Current Assets 0.00 0.00 0.00 0.00
Total Current Assets 88.28M 104.62M 66.65M 109.68M
Property, Plant & Equipment, Gross 14.09M 13.53M 11.94M 10.70M
Accumulated Depreciation & Depletion 9.97M 8.50M 9.51M 8.10M
Property, Plant & Equipment, Net 4.12M 5.03M 2.44M 2.60M
Intangibles 0.00 0.00 0.00 0.00
Other Non-Current Assets 23.55M 442.00K 709.00K 267.00K
Total Non-Current Assets 39.28M 5.47M 3.15M 2.87M
Liabilities & Shareholder Equity
Total Assets 127.56M 110.09M 69.80M 112.55M
Accounts Payable 2.15M 8.84M 2.58M 8.29M
Short Term Debt 299.00K 398.00K 1.04M 1.29M
Other Current Liabilities 0.00 0.00 0.00 0.00
Total Current Liabilities 10.46M 9.24M 19.26M 16.22M
Long Term Debt 14.17M 299.00K 0.00 1.04M
Deferred Income Taxes 9.19M 30.42M 0.00 0.00
Other Non-Current Liabilities 47.99M 908.00K 20.95M 30.35M
Minority Interest 0.00 0.00 0.00 0.00
Total Non-Current Liabilities 71.35M 31.62M 20.95M 31.40M
Total Liabilities 81.81M 40.87M 40.20M 47.62M
Preferred Stock Equity 0.00 0.00 0.00 0.00
Common Stock Equity 45.75M 69.22M 29.59M 64.93M
Common Par 679.00K 556.00K 407.00K 406.00K
Additional Paid In Capital 423.59M 387.54M 299.28M 290.25M
Cumulative Translation Adjustment 0.00 0.00 0.00 0.00
Retained Earnings -378.52M -318.89M -270.10M -225.69M
Treasury Stock 0.00 0.00 0.00 0.00
Other Equity Adjustments 1.00K 14.00K 4.00K -28.00K
Total Capitalization 59.92M 69.52M 29.59M 65.98M
Total Equity 45.75M 69.22M 29.59M 64.93M
Total Liabilities & Stock Equity 127.56M 110.09M 69.80M 112.55M
Total Common Shares Outstanding 61.98M 49.63M 34.65M 34.51M
Preferred Shares 0.00 0.00 0.00 0.00
Treasury Shares 0.00 0.00 0.00 0.00
Basic Weighted Shares Outstanding 51.29M 45.57M 34.57M 27.73M
Diluted Weighted Shares Outstanding 51.29M 45.57M 34.57M 27.73M
Number of Employees 92 112 96 99
Number of Part-Time Employees 0 0 0 0
FOLD News

FOLD Amicus Therapeutics Inc

Analysts Ratings for FOLD

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 3 3 2 0
Moderate Buy 0 0 0 0
Hold 0 0 0 3
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
GET FOLD ANALYST REPORT

Brokerage Partners

FOLD Chatter

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Real Money Pro

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Trifecta Stocks

Trifecta Stocks analyzes over 4,000 equities weekly to find the elite 1% of stocks that pass rigorous quantitative, fundamental and technical tests.

Product Features:
  • Model portfolio
  • Trade alerts
  • Recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
Stocks Under $10

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Dividend Stock Advisor

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Breakout Stocks

Bryan Ashenberg, using sophisticated stock screening and fundamental research, identifies potentially explosive small and mid-cap stocks.

Product Features:
  • Model portfolio
  • Small-cap and mid-cap focus
  • Intraday trade alerts
  • Weekly roundups
Options Profits

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
Top Rated Stocks Top Rated Funds Top Rated ETFs